ArticleACS medicinal chemistry letters2023

Potent and Selective BCL-XL Inhibitors and PROTAC Compounds as Potential Cancer Treatment and Immunotherapy.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.